Meridian Wealth Management LLC acquired a new position in shares of UBS AG FI Enhanced Large Cap Growth ETN (NYSEARCA:FBGX – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 314 shares of the company’s stock, valued at approximately $218,000. Meridian Wealth Management LLC owned about 0.13% of UBS AG FI Enhanced Large Cap Growth ETN as of its most recent SEC filing. Other large investors have also bought and sold shares of the company. CRA Financial Services LLC bought a new position in shares of UBS AG FI Enhanced Large Cap Growth ETN in the 4th quarter valued at $211,000. David J Yvars Group acquired a new position in UBS AG FI Enhanced Large Cap Growth ETN in the 4th quarter worth about $213,000. Finally, Avantax Advisory Services Inc. bought a new position in UBS AG FI Enhanced Large Cap Growth ETN in the fourth quarter valued at about $243,000. UBS AG FI Enhanced Large Cap Growth ETN Stock Performance NYSEARCA:FBGX opened at $861.42 on Monday. The stock’s 50-day moving average is $815.87 and its 200-day moving average is $746.31. UBS AG FI Enhanced Large Cap Growth ETN has a 1-year low of $498.35 and a 1-year high of $869.52. UBS AG FI Enhanced Large Cap Growth ETN Profile (Free Report) The UBS AG FI Enhanced Large Cap Growth ETN (FBGX) is an exchange-traded fund that is based on the Russell 1000 Growth index. The fund provides 2X levered exposure to the total return of the Russell 1000 Growth Index, with quarterly leverage resets. FBGX was launched on Jun 11, 2014 and is issued by UBS. See Also Five stocks we like better than UBS AG FI Enhanced Large Cap Growth ETN What is the Nikkei 225 index? JD’s Earnings Could Mean Chinese Stocks Making a Comeback 3 Must-Buy Warren Buffett Stocks for Volatile Times Canada Goose Flies Higher Driven By DTC Growth 3 Fintech Stocks With Good 2021 Prospects CVS Health Stock Has a Silver Lining Called Value
| ARCA Exchange | US Country |
The UBS AG FI Enhanced Large Cap Growth ETN due June 19, 2024, represents a series of Financial Instruments (FI) Enhanced Exchange-Traded Notes (ETNs) offered by UBS AG. These securities are designed to provide investors with a leveraged exposure to an underlying index, which consists of large-cap growth stocks. The ETNs are specifically structured to amplify the returns of the index, offering two times the leverage on both the positive and negative quarterly performance. This means that investors stand to gain double the index's positive returns but are also exposed to double the risk should the index perform negatively. The performance of the index is calculated not only based on the price movements of the constituent securities but also takes into account the reinvestment of dividends paid by these securities, offering a comprehensive reflection of their total return.
This product is a leveraged exchange-traded note that offers investors amplified exposure to the performance of an underlying index comprised of large-cap growth stocks. The ETNs aim to deliver twice the quarterly performance of the index, adjusted for the reinvestment of dividends. This means that if the index sees a positive return, the ETN aims to double that return to its investors. Conversely, in the event of a negative return from the index, investors would be exposed to double the loss. It's an investment product suited for those looking to potentially magnify their investment outcomes, both positive and negative, through leverage.